Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.
Date AA, Nagarsenker MS. Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. J Pharm Pharmacol. 2007 Nov; 59(11):1583-4.